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UNH Study Examines Factors that Impact






DURHAM, N.H. -- A study between the University of New
Hampshire and the Washington University School of Medicine has
been awarded a grant exceeding $400,000 by the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK) to examine
various factors that may affect long-term kidney transplantation graft
survival.
According to Robert Woodward, Forrest D. McKerley Professor of
Health Economics at UNH and the principal investigator, the study
will expand upon his work previously published in the American
Journal of Transplantation in 2001. The study demonstrated that low-
income recipients had significantly greater graft loss after Medicare
coverage of immunosuppressive medications ended. At that time,
Woodward was a professor in Washington University's graduate
health administration program.
This finding was important, because 75 percent of the approximately
13,000 individuals who receive kidney transplants each year fall into
the low-income category defined in the study as those making less
than $36,000 annually.
"The long-term survival of a kidney transplant requires that the
recipient take expensive immunosuppressive medications for the life
of the transplant," Woodward says. "The cost of these medications
averages $12,000 per year. Unfortunately, the inability to afford these
medications and subsequent noncompliance is one of the most
common causes of graft loss after Medicare's coverage expires."
In the new study, the researchers will expand upon these
investigations, examining factors such as race, cost of medications,
Medicaid regulations, and state specific programs.
"We know, for example, that graft failure rates for African-Americans
are substantially higher than those for Caucasians," Woodward says.
"We're interested, among other things, in the extent to which race
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affects the inter-relationship between income, Medicare insurance and
immunosuppression prices."
Because individuals with end-state renal disease qualify for Medicare
insurance coverage regardless of age, Woodward explains, it is the
primary payer for more than 70 percent of kidney transplants and the
secondary payer for many others.
In 1986 Medicare provided coverage for 80 percent of the cost of
outpatient immunosuppressive medications for one year following
kidney transplants. Between July 1993 and July 1995, Medicare
gradually extended this initial coverage to three years. After this
period, disabled individuals may qualify for Medicaid, but eligibility
requirements vary by state.
"Medicare's change from one to three years immunosuppression
coverage provides a natural experiment," Woodward says. "We
estimated impact of the extended coverage by comparing the periods
when only one year of coverage was provided with three years of
coverage. And the forthcoming release of another year's data from the
United States Renal Data System will enable a third comparison: Did
the loss of insurance after three years increase the graft loss more
among low-income recipients in patients transplanted since July
1995?"
The results of this project will provide guidance to both Medicare and
state policy-makers responsible for determining the length of
immunosuppression coverage, Woodward says.
"Specifically, it will identify those patients for which insurance had
the greatest impact," he says. The results will also guide physicians in
selecting among immunosuppressive medications with widely
variable prices by identifying those patient groups for whom out-of-
pocket price is an important determinant of long-term graft survival."
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